Cargando…
Remote electrical neuromodulation (REN) wearable device for adolescents with migraine: a real-world study of high-frequency abortive treatment suggests preventive effects
INTRODUCTION: Migraine is a chronic neurological disease manifesting as attacks of disabling head pain and associated symptoms. Remote electrical neuromodulation (REN) is a non-pharmacological, prescribed, wearable device (Nerivio®). This device has been certified by the FDA for the acute and/or pre...
Autores principales: | Monteith, Teshamae S., Stark-Inbar, Alit, Shmuely, Sharon, Harris, Dagan, Garas, Sandy, Ironi, Alon, Kalika, Paige, Irwin, Samantha L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657883/ https://www.ncbi.nlm.nih.gov/pubmed/38028429 http://dx.doi.org/10.3389/fpain.2023.1247313 |
Ejemplares similares
-
Real-World Analysis of Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine
por: Ailani, Jessica, et al.
Publicado: (2022) -
Remote electrical neuromodulation (REN) in the acute treatment of migraine: a comparison with usual care and acute migraine medications
por: Rapoport, Alan M., et al.
Publicado: (2019) -
Incorporating Remote Electrical Neuromodulation (REN) Into Usual Care Reduces Acute Migraine Medication Use: An Open-Label Extension Study
por: Marmura, Michael J., et al.
Publicado: (2020) -
Remote Electrical Neuromodulation (REN) for the Acute Treatment of Menstrual Migraine: a Retrospective Survey Study of Effectiveness and Tolerability
por: Nierenburg, Hida, et al.
Publicado: (2021) -
Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Trial
por: Yarnitsky, David, et al.
Publicado: (2019)